This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Celixir (previously trading as Cell Therapy) is a British pioneer in Regenerative Medicine. Its team of scientists and biotechnology leadership is devoted to discovering breakthrough medicines that aim to change the standard of medical care for patients.

  • Amount raised

    £689.25k

  • Company number

    06970743

  • Incorporation date

    23/07/2009

Details

  • Company number

    06970743

  • Incorporation date

    23/07/2009

  • Company status

    Active

  • Industry type

    Other research and experimental development on natural sciences and engineering

  • Number of current appointments

    4

Celixir House Stratford-Upon-Avon Business & Technology Park
Innovation Way
Stratford-Upon-Avon
CV37 7GZ

Crowdcube Funding History

Date Amount No. of Investors
01/12/2014 £689.25k 297 View

Key Financials

View all financials
2018 2019
Turnover £715.38k £765.11k
Cash £5.23m £1.79m
Increase in Cash - -

Financial data drawn from last filed accounts don't necessarily reflect current trading activity.

Date Description Type
16/03/2020

Termination of appointment of David William Preston as a secretary on 2020-03-16

PDF
05/02/2020

Full accounts made up to 2019-07-31

PDF
09/08/2019

Confirmation statement made on 2019-07-23 with no updates

PDF

People

Name Role Appointed Nationality
EVANS, Martin John, Sir Director 09/07/2009 British
REGINALD, Trevor Ajan Director 12/06/2012 British
SHEIKH, Mubasher Director 12/08/2012 British
CELIXIR PLC Corporate-director 19/01/2019